中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
异丁基二(羟甲基)氨基甲酸酯 | 3-Hydroxy-1-propan-2-ylpyridin-4-one | 104764-53-6 | C8H11NO2 |
|
异丁基3-氧代-3H-吩恶嗪-7-基碳酸酯 | 7-(Isobutoxycarbonyloxy)-3H-phenoxazin-3-one | 251292-24-7 | C17H15NO5 |
|
异丁基(1,3-噻唑-2-基硫代氨基甲酰)氨基甲酸酯 | N-Isobutoxycarbonyl-N'-(2-thiazolyl)thioharnstoff | 39142-37-5 | C9H13N3O2S2 |
|
异丁嗪杂质B(EP) | methyl-(γ-phenothiazin-10-yl-isobutyl)-amine | 22732-04-3 | C17H20N2S |
|
异丁嗪 | Alimemazine | 84-96-8 | C18H22N2S |
|
异丁司特 | ibudilast | 50847-11-5 | C14H18N2O |
|
康奈非尼 | encorafenib | 1269440-17-6 | C22H27ClFN7O4S |
|
度鲁特韦钠盐 | (4R,12AS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, sodium sa | 1051375-19-9 | C20H19F2N3NaO5 |
|
度鲁特韦杂质7 | Desdifluoro dolutegravir | 2244161-71-3 | C20H21N3O5 |
|
度鲁特韦杂质6 | dolutegravir | 1357289-29-2 | C20H19F2N3O5 |
|
度鲁特韦杂质3 | N-(2,4-difluorobenzyl)-2,8-dihydro-9-hydroxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-1H-pyrido[1,2-a]-pyrazine-7-carboxamide | 1973402-05-9 | C20H19F2N3O5 |
|
度鲁特韦杂质16 | Fgd6spp2VH | 1357289-37-2 | C20H19F2N3O5 |
|
度鲁特韦杂质 | 4-Defluoro dolutegravir | 1863916-87-3 | C20H20FN3O5 |
|
度鲁特韦中间体-6 | methyl 1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylate | 1206102-07-9 | C17H19NO6 |
|
度鲁特韦中间体-3 | 3-(benzyloxy)-4-oxo-4H-pyran-2-carbaldehyde | 500371-01-7 | C13H10O4 |
|
度鲁特韦 | dolutegravir | 1051375-16-6 | C20H19F2N3O5 |
|
度莫辛 | Domoxin | 61-74-5 | C16H18N2O2 |
|
度美辛 | 3-p-Methoxy-2-methyl-6-methoxyindol-1-yl-essigsaeure | 25771-23-7 | C20H19NO5 |
|
度硫平砜 | 11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenzo(b,e)thiepine-5,5-dioxide | 25846-81-5 | C19H21NO2S |
|
度琉平 | dosulepin | 25627-38-7 | C19H21NS |
|
度琉平 | dothiepin | 113-53-1 | C19H21NS |
|
度洛西汀杂质12 | (E)-N,N-dimethyl-3-(2-thienyl)-2-propene-1-ylamine | 81750-20-1 | C9H13NS |
|
度氟西泮 | doxefaxepam | 40762-15-0 | C17H14ClFN2O3 |
|
度奥哌隆 | (4-fluoro-phenyl)-{1-[3-(2-trifluoromethyl-phenothiazin-10-yl)-propyl]-piperidin-4-yl}-methanone | 62030-88-0 | C28H26F4N2OS |
|
庚基2-氯异烟酸酯 | Heptyl 2-chloroisonicotinate | 898784-92-4 | C13H18ClNO2 |
|
庚基2-(1H-吲哚-3-基)乙酸酯 | indol-3-yl-acetic acid heptyl ester | 2122-72-7 | C17H23NO2 |
|
底米鎓 | (3-imino-5-methyl-6-phenylphenanthridin-8-yl)azanium | —— | C20H18N3+ |
|
库马唑啉 | 2-<(2-Ethylbenzo<b>furan-3-yl)-methyl>-Δ<sup>2</sup>-imidazolin | 37681-00-8 | C14H16N2O |
|
库潘尼西盐酸 | Copanlisib hydrochloride | 1402152-13-9 | C23H30Cl2N8O4 |
|
库潘尼西 | copanlisib | 1032568-63-0 | C23H28N8O4 |
|
并四噻吩 | thieno<2'',3'':4',5'>thieno<2',3'-d>thieno<3,2-b>thiophene | 124796-78-7 | C10H4S4 |
|
帽柱叶碱 | mitraphylline | 509-80-8 | C21H24N2O4 |
|
常绿钩吻碱 | Sempervirine cation | 6882-99-1 | C19H17N2+ |
|
常山酮氢溴酸盐 | halofuginone hydrobromide | —— | BrH*C16H17BrClN3O3 |
|
常山酮内酯 | Halocur | 82186-71-8 | C19H23BrClN3O6 |
|
常山乙素 | febrifugine | 24159-07-7 | C16H19N3O3 |
|
常咯啉 | Changrolin | 72063-47-9 | C24H29N5O |
|
带色离子载体VI | Chromoionophore VI | 138833-47-3 | C38H46Br2O5 |
|
带色离子载体(pH指示剂)I | Chromoionophore I | 125829-24-5 | C38H53N3O2 |
|
帕马溴 | pamabrom | 606-04-2 | C4H11NO*C7H7BrN4O2 |
|
帕马喹 | pamaquine | 491-92-9 | C19H29N3O |
|
帕那普隆 | Panadiplon | 124423-84-3 | C18H17N5O2 |
|
帕西伏尼 | (4R)-4-(2-chloro-2,2-difluoroethyl)-1-[[2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl]methyl]pyrrolidin-2-one | 1294000-61-5 | C14H14ClF5N4O2S |
|
帕苯达唑 | parbendazole | 14255-87-9 | C13H17N3O2 |
|
帕苏沙星(甲磺酸盐) | Pazufloxacin mesylate | 163680-77-1 | C17H19FN2O7S |
|
帕罗醇甲烷磺酸酯 | ((3S,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methyl methanesulfonate | 608521-21-7 | C14H20FNO3S |
|
帕罗西汀杂质6 | (3R,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine | 100332-12-5 | C13H18FNO |
|
帕罗西汀杂质45 | trans 4-(p-fluorophenyl)-3-(p-toluenesulfonyloxymethyl)-N-methylpiperidine | 1258537-32-4 | C20H24FNO3S |
|
帕罗西汀杂质38(单体) | BH2R3Mvs74 | 1217975-87-5 | C25H24FNO3 |
|
帕罗西汀杂质05 | Paroxetine, cis-(+/-)- | 1396174-70-1 | C19H20FNO3 |
|